A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin

被引:132
作者
Fraser, Callum G. [1 ]
Allison, James E. [2 ,3 ]
Halloran, Stephen P. [4 ]
Young, Graeme P. [5 ]
机构
[1] Univ Dundee, Ctr Res Canc Prevent & Screening, Dundee DD1 9SY, Scotland
[2] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
[3] Kaiser Permanente No Calif Div Res, Oakland, CA USA
[4] Royal Surrey Cty Hosp NHS Fdn Trust, Bowel Canc Screening So Programme Hub, Guildford, Surrey, England
[5] Flinders Univ S Australia, Ctr Canc Prevent & Control, Adelaide, SA 5001, Australia
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2012年 / 104卷 / 11期
关键词
OCCULT BLOOD-TEST; CANCER SCREENING-PROGRAM; COLORECTAL-CANCER; PERFORMANCE; COLONOSCOPY; NEOPLASIA; UPDATE;
D O I
10.1093/jnci/djs190
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fecal immunochemical tests for hemoglobin are replacing traditional guaiac fecal occult blood tests in population screening programs for many reasons. However, the many available fecal immunochemical test devices use a range of sampling methods, differ with regard to hemoglobin stability, and report hemoglobin concentrations in different ways. The methods for sampling, the mass of feces collected, and the volume and characteristics of the buffer used in the sampling device also vary among fecal immunochemical tests, making comparisons of test performance characteristics difficult. Fecal immunochemical test results may be expressed as the hemoglobin concentration in the sampling device buffer and, sometimes, albeit rarely, as the hemoglobin concentration per mass of feces. The current lack of consistency in units for reporting hemoglobin concentration is particularly problematic because apparently similar hemoglobin concentrations obtained with different devices can lead to very different clinical interpretations. Consistent adoption of an internationally accepted method for reporting results would facilitate comparisons of outcomes from these tests. We propose a simple strategy for reporting fecal hemoglobin concentration that will facilitate the comparison of results between fecal immunochemical test devices and across clinical studies. Such reporting is readily achieved by defining the mass of feces sampled and the volume of sample buffer (with confidence intervals) and expressing results as micrograms of hemoglobin per gram of feces. We propose that manufacturers of fecal immunochemical tests provide this information and that the authors of research articles, guidelines, and policy articles, as well as pathology services and regulatory bodies, adopt this metric when reporting fecal immunochemical test results.
引用
收藏
页码:810 / 814
页数:5
相关论文
共 34 条
[1]   Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics [J].
Allison, James E. ;
Sakoda, Lori C. ;
Levin, Theodore R. ;
Tucker, Jo P. ;
Tekawa, Irene S. ;
Cuff, Thomas ;
Pauly, Mary Pat ;
Shlager, Lyle ;
Palitz, Albert M. ;
Zhao, Wei K. ;
Schwartz, J. Sanford ;
Ransohoff, David F. ;
Selby, Joseph V. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19) :1462-1470
[2]   Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed [J].
Allison, James E. ;
Fraser, Callum G. ;
Halloran, Stephen P. ;
Young, Graeme P. .
GASTROENTEROLOGY, 2012, 142 (03) :422-424
[3]   Colorectal Cancer Screening Guidelines: The Importance of Evidence and Transparency [J].
Allison, James E. .
GASTROENTEROLOGY, 2010, 138 (05) :1648-U28
[4]  
[Anonymous], 151892007 ISO
[5]   New faecal tests in gastroenterology [J].
Ayling, Ruth M. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2012, 49 :44-54
[6]   Sex Differences in Performance of Fecal Occult Blood Testing [J].
Brenner, Hermann ;
Haug, Ulrike ;
Hundt, Sabrina .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (11) :2457-2464
[7]   Inter-test agreement and quantitative cross-validation of immunochromatographical fecal occult blood tests [J].
Brenner, Hermann ;
Haug, Ulrike ;
Hundt, Sabrina .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (07) :1643-1649
[8]  
Clinical and Laboratory Standards Institute (CLSI), 2008, EP12A CLSI EP12A CLSI
[9]   Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper [J].
Duffy, Michael J. ;
van Rossum, Leo G. M. ;
van Turenhout, Sietze T. ;
Malminiemi, Outi ;
Sturgeon, Catherine ;
Lamerz, Rolf ;
Nicolini, Andrea ;
Haglund, Caj ;
Holubec, Lubos ;
Fraser, Callum G. ;
Halloran, Stephen P. .
INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (01) :3-11
[10]   Faecal occult blood tests - eliminate, enhance or update? [J].
Fraser, Callum G. .
ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 :117-121